Skip to main content

Table 3 Regulatory B cells percentages in different treatment subgroups

From: Frequency of CD19+CD24hiCD38hi regulatory B cells is decreased in peripheral blood and synovial fluid of patients with juvenile idiopathic arthritis: a preliminary study

  No DMARD DMARD p value No anti-TNF Anti-TNF p value
B cells (%) 14.96 ± 0.87 (n = 14) 16.19 ± 4.48 (n = 6) 0.7006 13.41 ± 1.07 (n = 8) 16.61 ± 2.20 (n = 12) 0.2757
CD24hiCD38hi Bregs (% in B cells) 17.11 ± 1.12 (n = 11) 13.38 ± 2.43 (n = 4) 0.1358 18.08 ± 1.42 (n = 6) 14.80 ± 1.45 (n = 9) 0.1469
B10 cells (% in B cells) 7.25 ± 1.14 (n = 14) 7.73 ± 2.30 (n = 5) 0.8408 6.16 ± 1.48 (n = 7) 8.09 ± 1.34 (n = 12) 0.3683
  1. Bregs regulatory B cells, B10 cells IL-10 producing regulatory B cells, DMARD disease-modifying antirheumatic drug, JIA juvenile idiopathic arthritis, PB peripheral blood, SF synovial fluid, TNF tumor necrosis factor